When did TAYSHA GENE THERAPIES INC (TSHA) report earnings last quarter?
TAYSHA GENE THERAPIES INC (TSHA) last reported earnings on 3/19/2026.
TAYSHA GENE THERAPIES INC (TSHA) Earnings History & Surprises
NASDAQ:TSHA • US8776191061
Current stock price
6.43 USD
+0.48 (+8.07%)
At close:
6.4 USD
-0.03 (-0.47%)
After Hours:
TSHA Earnings overview
Past quarterly earnings results for TAYSHA GENE THERAPIES INC (TSHA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.10
- Revenue Estimate
- 693.6K
Last Reported
Most Recent- Release Date
- Mar 19, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.08
- EPS Surprise
- 18.43%
- Revenue Surprise
- 184.64%
Beat Rate
Last 8 Quarters 63%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.08 | -0.10 | 18.43% | -14.29% | 5.485M | 1.927M | 184.64% | 171.27% |
| Q3 2025 | -0.09 | -0.09 | -0.01% | 10.00% | 1.409M | -100.00% | -100.00% | |
| Q2 2025 | -0.09 | -0.08 | -9.04% | - | 1.986M | 1.637M | 21.32% | 78.60% |
| Q1 2025 | -0.08 | -0.09 | 15.26% | 20.00% | 2.302M | 1.51M | 52.45% | -32.51% |
| Q4 2024 | -0.07 | -0.08 | 17.32% | -107.61% | 2.022M | 2.355M | -14.14% | -43.90% |
| Q3 2024 | -0.10 | -0.09 | -5.87% | 23.08% | 1.788M | 1.681M | 6.37% | -62.33% |
| Q2 2024 | -0.09 | -0.17 | 46.41% | 76.32% | 1.112M | 2.717M | -59.07% | -53.57% |
| Q1 2024 | -0.10 | -0.11 | 10.38% | 64.29% | 3.411M | 2.612M | 30.59% | -27.52% |
| Q4 2023 | 0.92 | -0.11 | 919.96% | 370.59% | 3.604M | 2.703M | 33.33% | 44.16% |
| Q3 2023 | -0.13 | -0.18 | 26.20% | 79.69% | 4.746M | 2.141M | 121.67% | - |
| Q2 2023 | -0.38 | -0.32 | -19.75% | 54.76% | 2.395M | 1.9M | 26.05% | - |
| Q1 2023 | -0.28 | -0.36 | 22.48% | 78.63% | 4.706M | 1.02M | 361.37% | - |
| Q4 2022 | -0.34 | -0.34 | -1.25% | 74.24% | 2.5M | 8.345M | -70.04% | - |
| Q3 2022 | -0.64 | -0.83 | 23.17% | 52.59% | - | - | ||
| Q2 2022 | -0.84 | -1.02 | 18.03% | 22.94% | - | - | ||
| Q1 2022 | -1.31 | -1.09 | -20.35% | -50.57% | - | - | ||
| Q4 2021 | -1.32 | -1.28 | -3.12% | -26.92% | - | - | ||
| Q3 2021 | -1.35 | -1.10 | -22.74% | -5.47% | - | - | ||
| Q2 2021 | -1.09 | -0.86 | -27.27% | - | - | - | ||
| Q1 2021 | -0.87 | -0.57 | -51.55% | - | - | - | ||
| Q4 2020 | -1.04 | -0.38 | -171.90% | - | - | - | ||
| Q3 2020 | -1.28 | -0.18 | -617.09% | - | - | - | ||
| Q2 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
6.16%
Max EPS beat (4)
18.43%
Min EPS beat (4)
-9.04%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
39.60%
Max Revenue beat (4)
184.64%
Min Revenue beat (4)
-100.00%
Analysis
In the last 4 quarters, TSHA has beaten EPS estimates in 2 out of 4 releases
TSHA has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, TSHA has beaten the EPS estimates by 6.2% on average.
In the last 4 quarters, TSHA has beaten the revenue estimates by 39.6% on average.
Related analysis
TAYSHA GENE THERAPIES INC / TSHA Earnings FAQ
Can you provide information on whether TAYSHA GENE THERAPIES INC beat earnings estimates in the last quarter?
TAYSHA GENE THERAPIES INC (TSHA) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does TAYSHA GENE THERAPIES INC (TSHA) beat earnings estimates?
In the last 4 quarters, TAYSHA GENE THERAPIES INC (TSHA) has beaten EPS estimates in 2 out of 4 releases.